Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Ballen

Showing results (151-160 of 164) with videos related to

Pageof 17
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 28, 2012
Allogeneic hematopoietic cell transplantation for advanced polycythemia vera and essential thrombocythemiaKaren K Ballen, Ann E Woolfrey, Xiaochun Zhu, et al.
Cancer|September 30, 2017
Cabozantinib is well tolerated in acute myeloid leukemia and effectively inhibits the resistance-conferring FLT3/tyrosine kinase domain/F691 mutationAmir T Fathi, Traci M Blonquist, Daniela Hernandez, et al.
Blood Advances|October 5, 2019
Myeloablative vs reduced intensity T-cell-replete haploidentical transplantation for hematologic malignancyScott R Solomon, Andrew St Martin, Nirav N Shah, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 28, 2014
Effect of cord blood processing on transplantation outcomes after single myeloablative umbilical cord blood transplantationKaren K Ballen, Brent R Logan, Mary J Laughlin, et al.
Bone Marrow Transplantation|November 18, 2014
Alternative donors extend transplantation for patients with lymphoma who lack an HLA matched donorV Bachanova, L J Burns, T Wang, et al.
Blood Advances|March 30, 2018
Third-party fecal microbiota transplantation following allo-HCT reconstitutes microbiome diversityZachariah DeFilipp, Jonathan U Peled, Shuli Li, et al.
Transplantation and Cellular Therapy|March 30, 2021
Worldwide Network for Blood and Marrow Transplantation (WBMT) Recommendations Regarding Essential Medications Required To Establish An Early Stage Hematopoietic Cell Transplantation ProgramRiad El Fakih, Hildegard Greinix, Mickey Koh, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 15, 2017
Outcomes after Umbilical Cord Blood Transplantation for Myelodysplastic SyndromesAaron T Gerds, Kwang Woo Ahn, Zhen-Huan Hu, et al.
Cancer|December 21, 2019
A phase 1 study of the antibody-drug conjugate brentuximab vedotin with re-induction chemotherapy in patients with CD30-expressing relapsed/refractory acute myeloid leukemiaRupa Narayan, Traci M Blonquist, Ashkan Emadi, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 29, 2013
Reduced-intensity hematopoietic cell transplantation for patients with primary myelofibrosis: a cohort analysis from the center for international blood and marrow transplant researchVikas Gupta, Adriana K Malone, Parameswaran N Hari, et al.
Pageof 17

Showing results (151-160 of 164) with videos related to

Sort By:
Pageof 17
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 28, 2012
Allogeneic hematopoietic cell transplantation for advanced polycythemia vera and essential thrombocythemiaKaren K Ballen, Ann E Woolfrey, Xiaochun Zhu, et al.
Cancer|September 30, 2017
Cabozantinib is well tolerated in acute myeloid leukemia and effectively inhibits the resistance-conferring FLT3/tyrosine kinase domain/F691 mutationAmir T Fathi, Traci M Blonquist, Daniela Hernandez, et al.
Blood Advances|October 5, 2019
Myeloablative vs reduced intensity T-cell-replete haploidentical transplantation for hematologic malignancyScott R Solomon, Andrew St Martin, Nirav N Shah, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 28, 2014
Effect of cord blood processing on transplantation outcomes after single myeloablative umbilical cord blood transplantationKaren K Ballen, Brent R Logan, Mary J Laughlin, et al.
Bone Marrow Transplantation|November 18, 2014
Alternative donors extend transplantation for patients with lymphoma who lack an HLA matched donorV Bachanova, L J Burns, T Wang, et al.
Blood Advances|March 30, 2018
Third-party fecal microbiota transplantation following allo-HCT reconstitutes microbiome diversityZachariah DeFilipp, Jonathan U Peled, Shuli Li, et al.
Transplantation and Cellular Therapy|March 30, 2021
Worldwide Network for Blood and Marrow Transplantation (WBMT) Recommendations Regarding Essential Medications Required To Establish An Early Stage Hematopoietic Cell Transplantation ProgramRiad El Fakih, Hildegard Greinix, Mickey Koh, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 15, 2017
Outcomes after Umbilical Cord Blood Transplantation for Myelodysplastic SyndromesAaron T Gerds, Kwang Woo Ahn, Zhen-Huan Hu, et al.
Cancer|December 21, 2019
A phase 1 study of the antibody-drug conjugate brentuximab vedotin with re-induction chemotherapy in patients with CD30-expressing relapsed/refractory acute myeloid leukemiaRupa Narayan, Traci M Blonquist, Ashkan Emadi, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 29, 2013
Reduced-intensity hematopoietic cell transplantation for patients with primary myelofibrosis: a cohort analysis from the center for international blood and marrow transplant researchVikas Gupta, Adriana K Malone, Parameswaran N Hari, et al.
Pageof 17